MGX vs SHOP · rev $25.2M vs P/E 107, rev $3.58B
Metagenomi, Inc. Common Stock (MGX) versus Shopify Inc (SHOP) — a side-by-side from cached financials, not a winner call.
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
Shopify Inc (SHOP) is a software - application company listed on US. It is led by Tobi Lutke.
Latest reported MGX revenue for 2025-12-31 was $25.2M. Net income was -$87.9M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. MGX currently screens at market cap $44.4M.
Latest reported SHOP revenue for 2026-06-30 was $3.58B. Net income was $1.50B. Revenue was up 13.0% from 2026-03-31 to 2026-06-30. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
MGX currently screens at market cap $44.4M. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
Not investment advice. Open the MGX and SHOP stock pages for the full models.
Not investment advice.